Details for Australian Trade Mark No. 1294374 (hide)

Owner PHARMACEUTICAL CO.LTD ZHEJIANG CHARIOTEER

Various The applicant has advised that the English translation of the words appearing in the trade mark is THE CHINESE WORD IN THE MARK MEANS CHARIOTEER.* The applicant has advised that the characters appearing in the trade mark may be transliterated as which may

Filing Date 12 December 2008

Classes

Class 5 Antipyretyc, analgesic and anti-inflammatory active pharmaceutical ingredient, namely naproxen, naproxen sodium, naproxen celecoxib, nimesulide, aceclofenac, sulindac, ibuprofen, fenoprofen, ketoprofen, celecoxib, nimesulide, aceclofenac; anti-inflammatory active pharmaceutical ingredient, namely naproxen nitroxyalkylesters; antipyretic and analgesic active pharmaceutical ingredient, namely aspirin, acetaminophen, propyphenazone; antipyretic and analgesic, antithrombotic active pharmaceutical ingredient, namely indomethacin; analgesic active pharmaceutical ingredient, namely eptazocine, ketorolac tromethamine; antipyretic, analgesic active pharmaceutical ingredient, namely propyphenazone; anti-inflammatory and anti-virus active pharmaceutical ingredient, namely amantadine hydrochloride; treating rheumatoid arthritis active pharmaceutical ingredient, namely flurbiprofen, meloxicam, phenylbutazone; anti-platelet aggregation active pharmaceutical ingredient, namely clopidogrel hydrogen sulfate; anti-platelet drugs active pharmaceutical ingredient, namely prasugrel; anti-cancer active pharmaceutical ingredient, namely topotecan hydrochloride, ifosfamide, mesna, irinotecan, camptothecin, 7-ethyl hydrol-camptothecin, docetaxel; treating iodine deficiency active pharmaceutical ingredient, namely iodine; anti-goitre expectorantand active pharmaceutical ingredient, namely potassium iodide; treating supraventricular arrhythmia, typical angina and variant angina active pharmaceutical ingredient, namely diltiazem; anti-hepatitis B virus active pharmaceutical ingredient, namely adefovir dipivoxil, lamivudine, telbivudine, clevudine; anti-urogenital system disease active pharmaceutical ingredient, namely phenazopyridine hydrochloride; anti-virus active pharmaceutical ingredient, namely acyclovir, acyclovir sodium, penciclovir, zidovudine, ganciclovir, ganciclovir sodium, famciclovir, valaciclovir hydrochloride, valganciclovir hydrochloride, ribavirin, 6-deoxyacyclovir, polyinoosinic polycytidylic acid, interferons, adenine, farmivisen, docosanol, zanamvir, oseltamivir, indinavir, ritonavir, nelfinavir, delavirdine, efavirenz, ainprenavir, lopinavir, cidofovir, imiquimod, pegintron, didanosine, foscarnet sodium, penciclovir sodium, stavudine, abacavir, tenofovir disoproxil, emdtricitabine, brivudine, amprenavir, rimantadine; expectorant active pharmaceutical ingredient, namely fudosteine, carbocisteine; anti-hypertension active pharmaceutical ingredient namely valsartan, losartan, irbesartan, tasosartan, candesartan, telmisartan, eprosartan, olmesartan; anxiolytic active pharmaceutical ingredient, namely brofoxine; treating coronary heart disease active pharmaceutical ingredient, namely dipyridamole; immunosuppressive active pharmaceutical ingredient, namely tacrolimus; immunosuppressive agents active pharmaceutical ingredient, namely sirolimus; treating cardiac and cerebrovascular disease active pharmaceutical ingredient, namely nicergoline; treating coronary heart disease active pharmaceutical ingredient, namely isosorbide mononitrate; anti-obesity active pharmaceutical ingredient, namely orlistat; antipsychotic active pharmaceutical ingredient, namely perazine maleate, carisoprodol; anti-leprosy disease active pharmaceutical ingredient, namely thalidomide; anti-vitamin deficiency active pharmaceutical ingredient, namely folic acid, dexpanthenol; anti-megaloblastic anemia active pharmaceutical ingredient, namely calcium levofolinate; antithrombotic active pharmaceutical ingredient, namely ticlopidine hydrochloride; anti-rejection active pharmaceutical ingredient, namely rapamycin, mizoribine, mycophenolic acid, mycophenolate mofetil, mycophenolate sodium, clarithromycin, daptomycin, mupirocin, ertapenem, doripenem, biapenem, meropenem, imipenem, faropenem, aztreonam, benflumetol, mupirocin, caspofungin; treating diabetes mellitus active pharmaceutical ingredient, namely metformin, voglibose; antioxidant, treatment heart disease and antii-hypertension active pharmaceutical ingredient, namely coenzyme Q10; treating brain edema and glaucoma active pharmaceutical ingredient, namely isosorbide; anti-aids active pharmaceutical ingredient, namely nevirapine

Event Publications

14 May 2009 Application filed

28 May 2009 Application Accepted

24 September 2009 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1294375-FREE YOURSELF FROM THE COLD

1294373-ZICRON